Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1985 5
1986 8
1987 1
1991 1
1999 1
2000 2
2001 4
2002 3
2003 1
2004 2
2005 1
2006 2
2010 1
2011 3
2012 1
2013 1
2014 3
2015 1
2016 2
2017 5
2018 3
2019 3
2020 3
2021 6
2022 2
2023 4
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Brentuximab Vedotin with Chemotherapy for Stage III or IV Hodgkin's Lymphoma.
Connors JM, Jurczak W, Straus DJ, Ansell SM, Kim WS, Gallamini A, Younes A, Alekseev S, Illés Á, Picardi M, Lech-Maranda E, Oki Y, Feldman T, Smolewski P, Savage KJ, Bartlett NL, Walewski J, Chen R, Ramchandren R, Zinzani PL, Cunningham D, Rosta A, Josephson NC, Song E, Sachs J, Liu R, Jolin HA, Huebner D, Radford J; ECHELON-1 Study Group. Connors JM, et al. N Engl J Med. 2018 Jan 25;378(4):331-344. doi: 10.1056/NEJMoa1708984. Epub 2017 Dec 10. N Engl J Med. 2018. PMID: 29224502 Free PMC article. Clinical Trial.
Infections and Follicular Lymphoma: is there a Link?
Zallio F, Limberti G, Ladetto M. Zallio F, et al. Mediterr J Hematol Infect Dis. 2017 May 1;9(1):e2017035. doi: 10.4084/MJHID.2017.035. eCollection 2017. Mediterr J Hematol Infect Dis. 2017. PMID: 28512564 Free PMC article. Review.
BH3 mimetics in relapsed and refractory adult acute lymphoblastic leukemia: a Campus ALL real-life study.
Malfona F, Tanasi I, Piccini M, Papayannidis C, Federico V, Mancini V, Roncoroni E, Todisco E, Bianchi S, Ciotti G, Chiusolo P, Gentile M, Gianfelici V, Giglio F, Malagola M, Mulé A, Saraceni F, Vetro C, Zallio F, Cappelli LV, Pizzolo G, Foà R, Bonifacio M, Chiaretti S. Malfona F, et al. Among authors: zallio f. Haematologica. 2024 Mar 1;109(3):988-993. doi: 10.3324/haematol.2023.283684. Haematologica. 2024. PMID: 37794811 Free PMC article. No abstract available.
Changing Trends in B-Cell Non-Hodgkin Lymphoma Treatment: The Role of Novel Monoclonal Antibodies in Clinical Practice.
Tavarozzi R, Zacchi G, Pietrasanta D, Catania G, Castellino A, Monaco F, Gandolfo C, Rivela P, Sofia A, Schiena N, Bertassello C, Limberti G, Zallio F, Zanni M, Ladetto M. Tavarozzi R, et al. Among authors: zallio f. Cancers (Basel). 2023 Nov 13;15(22):5397. doi: 10.3390/cancers15225397. Cancers (Basel). 2023. PMID: 38001657 Free PMC article. Review.
The role of Bruton's kinase inhibitors (BTKi) in accelerated Chronic Lymphocytic Leukemia (a-CLL): a case of successful response to acalabrutinib.
Catania G, Tavarozzi R, Pini GM, Borra T, Gandolfo C, Zacchi G, Pietrasanta D, Monaco F, Zanni M, Lettieri M, Rivela P, Zallio F, Ladetto M. Catania G, et al. Among authors: zallio f. J Basic Clin Physiol Pharmacol. 2023 Apr 12;34(3):401-404. doi: 10.1515/jbcpp-2023-0051. eCollection 2023 May 1. J Basic Clin Physiol Pharmacol. 2023. PMID: 37040263
Significance of Degree of HLA Disparity Using T-cell Replete Peripheral Blood Stem Cells From Haploidentical Donors With Posttransplantation Cyclophosphamide in AML in First Complete Hematologic Remission: A Study of the Acute Leukemia Working Party of the EBMT.
Kharfan-Dabaja MA, Labopin M, Ayala E, Bazarbachi A, Blaise D, Vydra J, Bramanti S, Itälä-Remes M, Schmid C, Busca A, Forcade E, Rabitsch W, Zecca M, Kröger N, Bulabois CE, Grillo G, Rambaldi A, Fanin R, Zallio F, Di Renzo N, Koc Y, Novis Y, McDonald A, Herrera Arroyo C, Sanz J, Nagler A, Ciceri F, Mohty M. Kharfan-Dabaja MA, et al. Among authors: zallio f. Hemasphere. 2023 Jun 27;7(7):e920. doi: 10.1097/HS9.0000000000000920. eCollection 2023 Jul. Hemasphere. 2023. PMID: 37388926 Free PMC article.
High-dose sequential (HDS) chemotherapy for high-risk non-Hodgkin's lymphoma: long-term analysis and future developments.
Tarella C, Cuttica A, Caracciolo D, Zallio F, Ricca I, Bergui L, Gavarotti P, Marinone C, Pagano M, Rossi G, de Crescenzo A, Salomone A, Ladetto M, Boccadoro M, Pileri A. Tarella C, et al. Among authors: zallio f. Ann Hematol. 2001;80 Suppl 3:B123-6. doi: 10.1007/pl00022774. Ann Hematol. 2001. PMID: 11757693 Review. No abstract available.
The black swan: a case of central nervous system graft-versus-host disease.
Butera S, Tavarozzi R, Brunello L, Rivela P, Sofia A, Viero L, Salvio M, Ladetto M, Zallio F. Butera S, et al. Among authors: zallio f. J Basic Clin Physiol Pharmacol. 2023 Oct 17;34(6):805-809. doi: 10.1515/jbcpp-2023-0194. eCollection 2023 Nov 1. J Basic Clin Physiol Pharmacol. 2023. PMID: 37843253
Idelalisib exposure before allogeneic stem cell transplantation in patients with follicular lymphoma: an EBMT survey.
Sellner L, Schetelig J, Koster L, Choi G, Blaise D, Beelen D, Schianca FC, Passweg J, Schanz U, Gyan E, Sora F, Kröger N, Wulf GG, Van Gorkom G, Mayer J, Orvain C, Bourhis JH, Jindra P, Potter V, Zallio F, Vandenberghe E, Robinson S, Hayden PJ, Yakoub-Agha I, Montoto S, Dreger P; on behalf of the European Society for Blood and Marrow Transplantation Lymphoma and Chronic Malignancies Working Parties. Sellner L, et al. Among authors: zallio f. Bone Marrow Transplant. 2020 Dec;55(12):2335-2338. doi: 10.1038/s41409-020-0946-x. Epub 2020 May 22. Bone Marrow Transplant. 2020. PMID: 32444863 Free PMC article. No abstract available.
67 results